MedPath

QVAR REDIHALER

These highlights do not include all the information needed to use QVAR REDIHALER safely and effectively. See full prescribing information for QVAR REDIHALER.QVAR REDIHALER (beclomethasone dipropionate HFA) inhalation aerosol, for oral inhalation useInitial U.S. Approval: 1976

Approved
Approval ID

ccd3aaec-4892-40d0-ad60-3e570178fbe1

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 4, 2018

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Beclomethasone Dipropionate HFA

PRODUCT DETAILS

NDC Product Code50090-3459
Application NumberNDA207921
Marketing CategoryC73594
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateMay 17, 2018
Generic NameBeclomethasone Dipropionate HFA

INGREDIENTS (3)

BECLOMETHASONE DIPROPIONATEActive
Quantity: 80 ug in 1 1
Code: 5B307S63B2
Classification: ACTIB
NORFLURANEInactive
Code: DH9E53K1Y8
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
QVAR REDIHALER - FDA Approval | MedPath